Abstract:Background: Periprostatic (PP) adipose tissue surrounds the prostate, an organ with a high predisposition to become malignant. Frequently, growing prostatic tumor cells extend beyond the prostatic organ towards this fat depot. This study aimed to determine the genome-wide expression of genes in PP adipose tissue in obesity/overweight (OB/OW) and prostate cancer patients. Methods: Differentially expressed genes in human PP adipose tissue were identified using microarrays. Analyses were conducted according to the donors' body mass index characteristics (OB/OW versus lean) and prostate disease (extra prostatic cancer versus organ confined prostate cancer versus benign prostatic hyperplasia). Selected genes with altered expression were validated by real-time PCR. Ingenuity Pathway Analysis (IPA) was used to investigate gene ontology, canonical pathways and functional networks. Results: In the PP adipose tissue of OB/OW subjects, we found altered expression of genes encoding molecules involved in adipogenic/anti-lipolytic, proliferative/anti-apoptotic, and mild immunoinflammatory processes (for example, FADS1, down-regulated, and LEP and ANGPT1, both up-regulated). Conversely, in the PP adipose tissue of subjects with prostate cancer, altered genes were related to adipose tissue cellular activity (increased cell proliferation/differentiation, cell cycle activation and anti-apoptosis), whereas a downward impact on immunity and inflammation was also observed, mostly related to the complement (down-regulation of CFH). Interestingly, we found that the microRNA MIRLET7A2 was overexpressed in the PP adipose tissue of prostate cancer patients. Conclusions: Obesity and excess adiposity modified the expression of PP adipose tissue genes to ultimately foster fat mass growth. In patients with prostate cancer the expression profile of PP adipose tissue accounted for hypercellularity and reduced immunosurveillance. Both findings may be liable to promote a favorable environment for prostate cancer progression.

Obesity, Inflammation, and Prostate Cancer

Obesity, Inflammation, and Advanced Prostate Cancer

Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer

Obesity and prostate cancer — microenvironmental roles of adipose tissue

Mechanistic Insights into the Link between Obesity and Prostate Cancer

Diet and Tumor Genetics Conspire to Promote Prostate Cancer Metabolism and Shape the Tumor Microenvironment

Adipose Tissues Have Been Overlooked as Players in Prostate Cancer Progression

Application of Anti-Inflammatory Agents in Prostate Cancer

Obesity-associated inflammation induces androgenic to estrogenic switch in the prostate gland

Mechanisms by which obesity regulates inflammation and anti-tumor immunity in cancer

The Gut-Prostate Axis: A New Perspective of Prostate Cancer Biology through the Gut Microbiome

Research progresses on the role of adiponectin and its receptors in prostate cancer

High‐fat diet promotes prostate cancer growth through histamine signaling

Obesity-Related Cross-Talk between Prostate Cancer and Peripheral Fat: Potential Role of Exosomes

Gut Microbiota–Derived Short-Chain Fatty Acids Promote Prostate Cancer Growth via IGF1 Signaling

High-fat diet-induced adipokine and cytokine alterations promote the progression of prostate cancer in vivo and in vitro .

Obesity and prostate cancer: gene expression signature of human periprostatic adipose tissue

Reduced Number and Immune Dysfunction of CD4+ T Cells in Obesity Accelerate Colorectal Cancer Progression

Obesity, inflammation, and liver cancer

Hyperinsulinemia enhances interleukin-17-induced inflammation to promote prostate cancer development in obese mice through inhibiting glycogen synthase kinase 3-mediated phosphorylation and degradation of interleukin-17 receptor

Obesity and Cancer: the Oil That Feeds the Flame